FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014185433> ?p ?o ?g. }

• W2014185433 endingPage "120" @default.
• W2014185433 startingPage "117" @default.
• W2014185433 abstract "Twelve patients with superficial papillary transitional cell carcinoma of the bladder (pTa, pT1) were treated with six consecutive weekly intravesical instillations of Rubratin (in a dose of 1.5, 3.0, or 4.5 mg), a cell wall skeleton preparation of Nocardia rubra (NCW). The main objective of this study was to look for local immunomodulating effects of NCW and in the first four patients the effect on a marker lesion was also investigated.Local immunostimulation in all 12 patients was determined by (1) measurement of cytokine induction [interleukin 1 beta (IL1 beta), IL2, IL6, and tumor necrosis factor alpha (TNF alpha)], (2) leukocyte influx into the urine, and (3) phenotypic analysis of the lymphocyte fraction of these leukocytes.Significantly elevated levels of Rubratin-induced IL1 beta (P < 0.001), IL2 (P < 0.001), IL6 (P < 0.01), and TNF alpha (P < 0.001) were found compared to control pretherapy levels. Rubratin also induced leukocyte influx into the urine. Fluorescence-activated cell sorter (FACS) analysis of the urinary leukocytes indicated T-cell activation (IL2 receptor and HLA-DR expression), while in two out of five patients the CD4/CD8 ratios were increased. Urinary cytokine induction by Rubratin was comparable with cytokine induction observed in nonresponding bacillus Calmette-Guérin (BCG) patients (recurrent tumor within 6 months), but less compared with responding BCG patients (no recurrent tumor within 6 months). Clinical results showed no response on the marker lesion and in five out of eight patients early recurrence was found after complete transurethral resection (TUR) of the bladder tumors. This biological response modifier caused no local or systemic side effects at the doses used.Although local immunostimulation by intravesical Rubratin administration can be induced, the amount of immunocompetent cells attracted to the bladder is not as high as observed in BCG-responding patients, resulting in lower amounts of cytokines produced. This could also explain the lack of clinical efficacy." @default.
• W2014185433 created "2016-06-24" @default.
• W2014185433 creator A5009626204 @default.
• W2014185433 creator A5049403397 @default.
• W2014185433 creator A5074829451 @default.
• W2014185433 creator A5084977302 @default.
• W2014185433 date "1997-03-01" @default.
• W2014185433 modified "2023-10-06" @default.
• W2014185433 title "Immunostimulation in the urinary bladder by local application ofNocardia rubra cell wall skeleton preparation (Rubratin) for superficial bladder cancer immunotherapy — a phase I/II study" @default.
• W2014185433 cites W1423791052 @default.
• W2014185433 cites W1528484004 @default.
• W2014185433 cites W1709508 @default.
• W2014185433 cites W1709779776 @default.
• W2014185433 cites W1927181513 @default.
• W2014185433 cites W1969800450 @default.
• W2014185433 cites W1975679320 @default.
• W2014185433 cites W1988263158 @default.
• W2014185433 cites W2016971744 @default.
• W2014185433 cites W2018664504 @default.
• W2014185433 cites W2019492645 @default.
• W2014185433 cites W2059198177 @default.
• W2014185433 cites W2066361967 @default.
• W2014185433 cites W2070936265 @default.
• W2014185433 cites W2089600290 @default.
• W2014185433 cites W2111442523 @default.
• W2014185433 cites W2153090784 @default.
• W2014185433 cites W2154293097 @default.
• W2014185433 cites W2414572565 @default.
• W2014185433 cites W2498271139 @default.
• W2014185433 cites W2503364349 @default.
• W2014185433 cites W3150167962 @default.
• W2014185433 doi "https://doi.org/10.1007/bf01037926" @default.
• W2014185433 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9144878" @default.
• W2014185433 hasPublicationYear "1997" @default.
• W2014185433 type Work @default.
• W2014185433 sameAs 2014185433 @default.
• W2014185433 citedByCount "19" @default.
• W2014185433 countsByYear W20141854332013 @default.
• W2014185433 countsByYear W20141854332016 @default.
• W2014185433 countsByYear W20141854332019 @default.
• W2014185433 countsByYear W20141854332022 @default.
• W2014185433 crossrefType "journal-article" @default.
• W2014185433 hasAuthorship W2014185433A5009626204 @default.
• W2014185433 hasAuthorship W2014185433A5049403397 @default.
• W2014185433 hasAuthorship W2014185433A5074829451 @default.
• W2014185433 hasAuthorship W2014185433A5084977302 @default.
• W2014185433 hasBestOaLocation W20141854332 @default.
• W2014185433 hasConcept C121608353 @default.
• W2014185433 hasConcept C126322002 @default.
• W2014185433 hasConcept C126894567 @default.
• W2014185433 hasConcept C142724271 @default.
• W2014185433 hasConcept C147483822 @default.
• W2014185433 hasConcept C167672396 @default.
• W2014185433 hasConcept C17991360 @default.
• W2014185433 hasConcept C203014093 @default.
• W2014185433 hasConcept C2777371288 @default.
• W2014185433 hasConcept C2777701055 @default.
• W2014185433 hasConcept C2778065480 @default.
• W2014185433 hasConcept C2778690821 @default.
• W2014185433 hasConcept C2779762690 @default.
• W2014185433 hasConcept C2780352672 @default.
• W2014185433 hasConcept C2781156865 @default.
• W2014185433 hasConcept C71924100 @default.
• W2014185433 hasConcept C77411442 @default.
• W2014185433 hasConceptScore W2014185433C121608353 @default.
• W2014185433 hasConceptScore W2014185433C126322002 @default.
• W2014185433 hasConceptScore W2014185433C126894567 @default.
• W2014185433 hasConceptScore W2014185433C142724271 @default.
• W2014185433 hasConceptScore W2014185433C147483822 @default.
• W2014185433 hasConceptScore W2014185433C167672396 @default.
• W2014185433 hasConceptScore W2014185433C17991360 @default.
• W2014185433 hasConceptScore W2014185433C203014093 @default.
• W2014185433 hasConceptScore W2014185433C2777371288 @default.
• W2014185433 hasConceptScore W2014185433C2777701055 @default.
• W2014185433 hasConceptScore W2014185433C2778065480 @default.
• W2014185433 hasConceptScore W2014185433C2778690821 @default.
• W2014185433 hasConceptScore W2014185433C2779762690 @default.
• W2014185433 hasConceptScore W2014185433C2780352672 @default.
• W2014185433 hasConceptScore W2014185433C2781156865 @default.
• W2014185433 hasConceptScore W2014185433C71924100 @default.
• W2014185433 hasConceptScore W2014185433C77411442 @default.
• W2014185433 hasIssue "2" @default.
• W2014185433 hasLocation W20141854331 @default.
• W2014185433 hasLocation W20141854332 @default.
• W2014185433 hasLocation W20141854333 @default.
• W2014185433 hasOpenAccess W2014185433 @default.
• W2014185433 hasPrimaryLocation W20141854331 @default.
• W2014185433 hasRelatedWork W1987350927 @default.
• W2014185433 hasRelatedWork W1994050787 @default.
• W2014185433 hasRelatedWork W2037602993 @default.
• W2014185433 hasRelatedWork W2188846409 @default.
• W2014185433 hasRelatedWork W2368159503 @default.
• W2014185433 hasRelatedWork W2381010098 @default.
• W2014185433 hasRelatedWork W2398878426 @default.
• W2014185433 hasRelatedWork W2409283273 @default.
• W2014185433 hasRelatedWork W2735230849 @default.
• W2014185433 hasRelatedWork W2118673085 @default.
• W2014185433 hasVolume "25" @default.

• next